Literature DB >> 6825804

Spontaneous AKR lymphomas differ in their degree of malignancy and sensitivity to the polysaccharide levan.

J Leibovici.   

Abstract

Spontaneous AKR lymphomas differ in their biological behavior as judged by formation of local tumors at the site of inoculation, latency in the appearance of both local and distant tumors and mean survival time of the mice. Spontaneous AKR lymphomas differ markedly in their sensitivity to levan (polyfructose). An inverse correlation was observed between the degree of malignancy and sensitivity to levan.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6825804     DOI： 10.1007/bf01955330

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  10 in total

1.  Inhibition of inflammatory response of skin to Staphylococcus aureus by high polymer levan.

Authors:  M SHILO; M WOLMAN; B WOLMAN
Journal:  Br J Exp Pathol       Date:  1956-04

2.  Infection-promoting activity of levan and dextran as a function of degree of polymerization.

Authors:  S HESTRIN; M SHILO; D S FEINGOLD
Journal:  Br J Exp Pathol       Date:  1954-04

3.  Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma.

Authors:  Y Sinai; J Leibovici; M Wolman
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

4.  Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice.

Authors:  J Leibovici; Y Sinai; M Wolman; G Davidai
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

5.  Observations on the changing behaviour of AKR mouse lymphomas serially transplanted in the strain of origin.

Authors:  P M Denton; M O Symes
Journal:  Immunology       Date:  1968-09       Impact factor: 7.397

Review 6.  Tumor heterogeneity and the biology of cancer invasion and metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

7.  Natural polyclonality of spontaneous AKR leukemia and its consequences for so-called specific immunotherapy.

Authors:  L Olsson; P Ebbesen
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

8.  Mechanism of the inhibitory effect of levan on experimental tumors.

Authors:  J Leibovici; Y Stark; T Eldar; G Brudner; M Wolman
Journal:  Recent Results Cancer Res       Date:  1980

9.  A method of comparing differences in tumour growth rates applied to a study of the increasing growth capacity of mouse carcinomata.

Authors:  J A Rees; M Westwood
Journal:  Br J Cancer       Date:  1974-02       Impact factor: 7.640

10.  The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.

Authors:  J Leibovici; A Borit; U Sandbank; M Wolman
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640
  10 in total
  3 in total

1.  Different biological behavior of AKR lymphoma cells from primary and metastatic tumors.

Authors:  J Leibovici; Y Stark; S Kopel
Journal:  Experientia       Date:  1985-03-15

2.  Sensitivity to thermochemotherapy of AKR lymphoma and B16 melanoma variants of malignancy.

Authors:  J Leibovici; G Klorin; M Huszar; S Hoenig; O Klein; M Michowitz; A Pinchassov
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

3.  Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.

Authors:  Y Stark; J Leibovici
Journal:  Br J Exp Pathol       Date:  1986-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.